PRIMARY STUDY
Effects of cannabinoids in Parkinson's disease animal models: a systematic review and meta-analysis
Key Findings: This systematic review finds that in animal studies cannabinoids can alleviate the motor symptoms of Parkinson's disease and supports the further clinical trials of cannabis in human populations.
Type of Study: Meta-analysis
Study Sample Size: 14
Study Result: Positive
Research Location(s): Australia
Year of Pub: 2022
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: Urbi B, et al. Effects of cannabinoids in Parkinson's disease animal models: a systematic review and meta-analysis. BMJ Open Sci. 2022; 6:e100302. doi: 10.1136/bmjos-2022-100302
Authors: Urbi B, Lee Y, Hughes I, Thorning S, Broadley SA, Sabet A, Heshmat S
